SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation

  • EMBO Rep. 2021 Nov 4;22(11):e51696. doi: 10.15252/embr.202051696.
Javier Rueda-Carrasco  1  2 María Jesús Martin-Bermejo  1  2 Guadalupe Pereyra  1  2 María Inés Mateo  1  2 Aldo Borroto  1 Frederic Brosseron  3  4 Markus P Kummer  3  4 Stephanie Schwartz  3  4 José P López-Atalaya  5 Balbino Alarcon  1 Pilar Esteve  1  2 Michael T Heneka  3  4 Paola Bovolenta  1  2
Affiliations
  • 1. Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.
  • 2. CIBER de Enfermedades Raras (CIBERER), Madrid, Spain.
  • 3. Neurology, Universitätsklinikum Bonn, Bonn, Germany.
  • 4. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • 5. Instituto de Neurociencias, CSIC-UMH, Sant Joan d'Alacant, Spain.
Abstract

Neuroinflammation is a common feature of many neurodegenerative diseases. It fosters a dysfunctional neuron-microglia-astrocyte crosstalk that, in turn, maintains microglial cells in a perniciously reactive state that often enhances neuronal damage. The molecular components that mediate this critical communication are not fully explored. Here, we show that secreted frizzled-related protein 1 (SFRP1), a multifunctional regulator of cell-to-cell communication, is part of the cellular crosstalk underlying neuroinflammation. In mouse models of acute and chronic neuroinflammation, SFRP1, largely astrocyte-derived, promotes and sustains microglial activation, and thus a chronic inflammatory state. SFRP1 promotes the upregulation of components of the hypoxia-induced factor-dependent inflammatory pathway and, to a lower extent, of those downstream of the nuclear factor-kappa B. We thus propose that SFRP1 acts as an astrocyte-to-microglia amplifier of neuroinflammation, representing a potential valuable therapeutic target for counteracting the harmful effect of chronic inflammation in several neurodegenerative diseases.

Keywords
Alzheimer's disease; HIF pathway; activated microglia; multiple sclerosis; reactive astrocytes.